Feature | By Amy Ballard, M.Ed., director of research, Arkansas Urology
Biomarkers are key indicators for pharmaceutical companies in determining which types of drugs to develop for various ...
June 09, 2008 
News
June 10, 2008 - At the Digestive Disease Week Conference, Cook Medical announced that it has been granted 510(k) clearance from the FDA for use of the Evolution Controlled Release Esophageal Stent System, a stent designed to improve the quality of life for patients with esophageal cancer.
June 09, 2008 News
June 10, 2008 – The design of the University of Chicago Medical Center’s New Hospital Pavilion offers flexibility by ...
June 09, 2008 Sponsored Content
Sponsored Content
Videos | Radiology Business
Radiology departments have many different needs and face a wide variety of challenges that can impact their departments ...
November 11, 2025 Feature | Cristen C. Bolan
Researchers are using speckle tracking imaging in heart ultrasound to monitor the health of transplant acceptance, and ...
June 09, 2008 Technology
Cook Medical's FDA-cleared Evolution Controlled Release Esophageal Stent System is a stent designed to improve the quality of life for patients with esophageal cancer.
June 09, 2008 News
June 10, 2008 – Screening for lung cancer with computed tomography (CT) may help reduce lung cancer deaths in current ...
June 09, 2008 Sponsored Content
Feature | Breast Imaging
Despite decades of progress in breast imaging, one challenge continues to test even the most skilled radiologists ...
October 24, 2025 News
June 10, 2008 – MEDSEEK, a provider of enterprise portal management solutions, said today it is supporting Microsoft ...
June 09, 2008 News
June 9, 2008 - Hologic Inc. said today that it has signed a definitive agreement to acquire Third Wave Technologies Inc ...
June 08, 2008 News
June 9, 2008 – American TeleCare Inc. (ATI) released Quick Notes as a new feature of its inLife/LifeView Telehealth ...
June 08, 2008 Sponsored Content
Sponsored Content
Videos | Radiology Business
Bayer Radiology’s Barbara Ruhland and Thom Kinst discuss how radiology departments can address the many different ...
October 09, 2025 
Technology
Toshiba Teli America introduced the T24MSA001-MD medical-grade 24-inch LCD color widescreen monitor with full HD (1,080 ...
June 08, 2008 Technology
ProHance is a macrocyclic, nonionic, gadolinium-based magnetic resonance imaging (MRI) contrast agent designed for use in MRI in adults and children over two years of age to visualize lesions with abnormal vascularity in the brain (intracranial lesions), spine and associated tissues. ProHance is also indicated for use in MRI in adults to visualize lesions in the head and neck.
June 08, 2008 News
June 9, 2008 - Cardinal Health today launched a new system that leverages the company’s dispensing technologies to ...
June 08, 2008 Sponsored Content
Case Study | PACS
eHealth Saskatchewan plays a vital role in providing IT services to patients, health care providers, and partners such ...
February 03, 2025 Technology
The FDA granted tentative approval for Covidien’s Abbreviated New Drug Application (ANDA) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien’s tentatively approved product is a generic of Cardiolite, which is a myocardial perfusion imaging agent used for detecting coronary artery disease.
June 08, 2008 News
June 9, 2008 - Siemens unveiled the ACUSON SC2000 volume imaging ultrasound system, which acquires nonstitched, real ...
June 08, 2008 Feature | Steven R. Renard
The Deficit Reduction Act of 2005 (DRA), which went into effect on January 1, 2007, has left its mark on hospitals and ...
June 08, 2008 
Technology
The FDA recently approved Covidien’s contrast delivery system with radiofrequency identification (RFID) technology ...
June 08, 2008 
Technology
The EmpowerMR injector system has multiple features created to cope with the problem of electrical interference in the ...
June 08, 2008 News
June 9, 2008 - Curlin Medical was recently awarded a three-year contract to provide its advanced pain management-local ...
June 08, 2008 
Technology
GE received FDA clearance for its new Signa MR750 3.0T scanner that delivers up to 60 percent additional anatomical ...
June 08, 2008 Technology
The ACIST CVi Contrast Delivery System provides one injection system for all cardiac and vascular angiography procedures. The variable-rate ACIST CVi system aims to provide ease of operation for clinicians, while obtaining quality images with less contrast used and delivered to the patient.
June 08, 2008 © Copyright Wainscot Media. All Rights Reserved.
Subscribe Now